/Investor DB

Pentech Ventures — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Causalycausaly.cominJul 2023 · $60M

Causaly builds an agentic AI platform for life sciences R&D that retrieves and reasons over scientific evidence, using a scientific knowledge graph and specialized AI agents to support target identification, indication discovery, and regulatory evidence validation.

AI & Machine LearningBiotechHealthtechLondon, GB

Yiannis Kiachopoulos(Co-founder & CEO)inArtur Saudabayev(Co-founder & CTO)inJoannis Kiahopoulos(Executive Officer, Director)Yiannis Kiachopoulos Artur Saudabayev(Founder)

BoardMarc Moens(Director)inGeorgios Tziralis(Director)

Co-investorsEBRD Venture Capital Investment ProgrammeEmerge EducationICONIQIndex VenturesMarathon Venture CapitalSNÖ Ventures+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.